Financials
Financial year 2025
Gross margin
€ 183,041
▼ 8% vs 2024
Profit
Growing€ 141,580
▲ 4% vs 2024
Debts
Low€ 80,570
▼ 78% vs 2024
Highland Life Sciences from Lasne, company number BE0760496727, closed financial year 2025 with a result of € 141,580 after tax. For that financial year Highland Life Sciences recorded a gross margin of € 183,041 and equity of € 520,572. Compared with financial year 2024, the result moved from € 136,500 to € 141,580. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
What happened at Highland Life Sciences?
What happened at Highland Life Sciences in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 141,580 (▲ 4% vs 2024). Source: NBB ↗
- New establishment in Lasne. KBO
- Start of the company according to the CBE. KBO
- Fabienne VAN DE KEERE became a director. NBB
- Vincent VLIEBERGH became a director. NBB
In short
From € 232,650 profit in 2021 to € 141,580 profit in 2025.
Paid € 354,903 in corporate taxes since 2021.
Best year ever: 2021, with € 232,650 profit.
Paid out € 225,915 in dividends to the owners in total.
A new publication or filing at Highland Life Sciences? We notify you, reason included.
Follow Highland Life SciencesNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Highland Life Sciences are Fabienne VAN DE KEERE and Vincent VLIEBERGH. The same people are also behind mazerine Partners, Charcot Stichting - Multiple Sclerose Overwinnen, SOIL CAPITAL BELGIUM, Hauteterre CS and Edaphon.
Directors
According to the 2025 annual accounts
since 2020
Vincent VLIEBERGH
Director
Also active at: Charcot Stichting - Multiple Sclerose Overwinnen, SOIL CAPITAL BELGIUM, Hauteterre CS +4 more
since 2020
Establishments
Establishment units
Physical locations of this company
Chemin du Bois Magonette 13
1380 Lasne
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Details
- Company number
- 0760.496.727
- VAT number
- BE 0760.496.727
- Registered office
- Chemin du Bois Magonette 13, 1380 Lasne
- Names & denominations
- Highland Life Sciences
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 December 2020
- Peppol
- Active · Active since 7 Jan 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering